A Wave of Drug-Free Alzheimer’s Treatment Innovation Offers New Hope | By Chuck Papageorgiou, CEO, NeuroEM Therapeutics
Chuck Papageorgiou writes: “With no effective prevention or long-term treatment, receiving a diagnosis of Alzheimer’s disease can seem like a fate worse than death for patients and their families and caregivers. However, a wave of innovation is bringing new hope to the 7 million Americans already living with Alzheimer’s disease and the 500,000 who will receive this devastating diagnosis each year.”
